Should I buy or sell Clover Health Investments stock right now?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Clover Health Investments in the last year. There are currently 1 sell rating, 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" CLOV shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CLOV, but not buy additional shares or sell existing shares. View CLOV analyst ratings or view top-rated stocks .

What is Clover Health Investments' stock price target for 2024?

3 brokers have issued 12-month target prices for Clover Health Investments' stock. Their CLOV share price targets range from $1.25 to $3.00. On average, they predict the company's stock price to reach $1.92 in the next twelve months. This suggests a possible upside of 101.7% from the stock's current price. View analysts price targets for CLOV or view top-rated stocks among Wall Street analysts .

How have CLOV shares performed in 2023?

Clover Health Investments' stock was trading at $0.9295 at the beginning of the year. Since then, CLOV shares have increased by 2.2% and is now trading at $0.9502. View the best growth stocks for 2023 here .

Are investors shorting Clover Health Investments?

Clover Health Investments saw a increase in short interest in November. As of November 15th, there was short interest totaling 25,430,000 shares, an increase of 5.3% from the October 31st total of 24,150,000 shares. Based on an average daily volume of 4,110,000 shares, the short-interest ratio is currently 6.2 days. View Clover Health Investments' Short Interest .

When is Clover Health Investments' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 27th 2024. View our CLOV earnings forecast .

How were Clover Health Investments' earnings last quarter?

Clover Health Investments, Corp. (NASDAQ:CLOV) issued its earnings results on Monday, November, 6th. The company reported ($0.09) earnings per share for the quarter, beating analysts' consensus estimates of ($0.10) by $0.01. The company earned $482.07 million during the quarter, compared to analysts' expectations of $491.30 million. Clover Health Investments had a negative trailing twelve-month return on equity of 75.65% and a negative net margin of 9.37%.

Who are Clover Health Investments' major shareholders?

Clover Health Investments' stock is owned by many different institutional and retail investors. Top institutional investors include PNC Financial Services Group Inc. (1.05%), Charles Schwab Investment Management Inc. (0.38%), Qube Research & Technologies Ltd (0.28%), Connor Clark & Lunn Investment Management Ltd. (0.17%), Northern Trust Corp (0.16%) and AQR Capital Management LLC (0.16%). Insiders that own company stock include Anna U Loengard, Chamath Palihapitiya , Chelsea Clinton and Lee Shapiro. View institutional ownership trends .

How do I buy shares of Clover Health Investments?

Shares of CLOV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull , Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here .

Clover Health Investments Stock Price, News & Analysis (NASDAQ:CLOV)

$0.95

+0.01 (+1.06%)

(As of 12/8/2023 ET)

Compare

Today's Range: $0.93
▼
$0.97
50-Day Range: $0.88
▼
$1.13
52-Week Range: $0.71
▼
$1.63

Volume: 5.48 million shs
Average Volume: 5.62 million shs
Market Capitalization: $463.36 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $1.92

Clover Health Investments MarketRank™ Stock Analysis

Analyst Rating: Hold
2.00 Rating Score
Upside/Downside: 101.7% Upside
$1.92 Price Target
Short Interest: Bearish
5.21% of Shares Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: 0.18
Based on 4 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: Growing
From ($0.53) to ($0.32) Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.63 out of 5 stars

Medical Sector

804th out of 942 stocks

Hospital & Medical Service Plans Industry

10th out of 11 stocks

3.0

Analyst's Opinion

Consensus Rating
Clover Health Investments has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on 1 buy rating, 1 hold rating, and 1 sell rating.
Price Target Upside/Downside
According to analysts' consensus price target of $1.92, Clover Health Investments has a forecasted upside of 101.7% from its current price of $0.95.
Amount of Analyst Coverage
Clover Health Investments has received no research coverage in the past 90 days.

1.0

Short Interest

Percentage of Shares Shorted
5.21% of the outstanding shares of Clover Health Investments have been sold short.
Short Interest Ratio / Days to Cover
Clover Health Investments has a short interest ratio ("days to cover") of 6.2.
Change versus previous month
Short interest in Clover Health Investments has recently increased by 5.30%, indicating that investor sentiment is decreasing significantly.

0.0

Dividend Strength

Dividend Yield
Clover Health Investments does not currently pay a dividend.
Dividend Growth
Clover Health Investments does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for CLOV.

1.8

News and Social Media Coverage

News Sentiment
Clover Health Investments has a news sentiment score of 0.18. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.51 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 4 news articles for Clover Health Investments this week, compared to 2 articles on an average week.
Search Interest
Only 18 people have searched for CLOV on MarketBeat in the last 30 days. This is a decrease of -28% compared to the previous 30 days.
MarketBeat Follows
Only 4 people have added Clover Health Investments to their MarketBeat watchlist in the last 30 days. This is a decrease of -20% compared to the previous 30 days.

1.7

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Clover Health Investments insiders have not sold or bought any company stock.
Percentage Held by Insiders
21.82% of the stock of Clover Health Investments is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
Only 19.95% of the stock of Clover Health Investments is held by institutions.

0.6

Earnings and Valuation

Earnings Growth
Earnings for Clover Health Investments are expected to grow in the coming year, from ($0.53) to ($0.32) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Clover Health Investments is -1.98, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Clover Health Investments is -1.98, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Clover Health Investments has a P/B Ratio of 1.30. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Clover Health Investments Stock (NASDAQ:CLOV)

Clover Health Investments, Corp. provides medicare advantage plans in the United States. The company through its Clover Assistant, a software platform that provides preferred provider organization and health maintenance organization health plans for medicare-eligible consumers. It also focuses on non-insurance businesses. The company was incorporated in 2014 and is based in Franklin, Tennessee.

CLOV Stock Price History

30 days | 90 days | 365 days | Advanced Chart

CLOV Stock News Headlines

December 5, 2023 | finance.yahoo.com

Clover Health Investments, Corp.'s (NASDAQ:CLOV) top owners are individual investors with 57% stake, while 23% is held by insiders

December 4, 2023 | markets.businessinsider.com

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Clover Health Investments (CLOV) and Biomea Fusion (BMEA)

December 9, 2023 | DTI Trader (Ad)

New CBOE “special perk” helps traders target income every weekend

You might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange.

December 4, 2023 | americanbankingnews.com

Clover Health Investments, Corp. (NASDAQ:CLOV) Short Interest Up 5.3% in November

December 1, 2023 | bizjournals.com

Profitability concerns lead Clover Health Investments to exit Centers for Medicare and Medicaid Services program

November 30, 2023 | usatoday.com

Clover vs. Square: Differences, pros and cons in 2023

November 26, 2023 | seekingalpha.com

CLOV Clover Health Investments, Corp.

November 10, 2023 | markets.businessinsider.com

Hold Rating on Clover Health Investments: Performance Upsides, Growth Concerns, and Capital Risk Factors

December 9, 2023 | Autonomix (Ad)

[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity

Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com

November 8, 2023 | finance.yahoo.com

Here's Why We're Not Too Worried About Clover Health Investments' (NASDAQ:CLOV) Cash Burn Situation

November 7, 2023 | markets.businessinsider.com

Hold Rating on Clover Health: Mixed Financial Performance and Future Uncertainty

November 7, 2023 | finance.yahoo.com

Q3 2023 Clover Health Investments Corp Earnings Call

November 7, 2023 | msn.com

Clover Health Investments, Augmedix among healthcare movers

November 7, 2023 | markets.businessinsider.com

What's Going On With Clover Health Stock Tuesday?

November 7, 2023 | finance.yahoo.com

Clover Health and WellBe Senior Medical Partner to Bring In-home Medical Care to Atlanta Patients and Across Rural Georgia

November 7, 2023 | seekingalpha.com

Clover Health Investments: Improving Fundamentals Inspires Bullish Outlook

November 7, 2023 | msn.com

Vegetarian restaurant chain Clover Food Lab files for bankruptcy

November 6, 2023 | finance.yahoo.com

Clover Health Reports Third Quarter 2023 Results; Highlights Continued Improvement in Financial Performance and Improved 2023 Guidance

November 6, 2023 | finance.yahoo.com

Clover Health Investments Corp (CLOV) Reports Q3 2023 Earnings: Improved Financial Performance ...

November 6, 2023 | seekingalpha.com

Clover Health Investments, Corp. 2023 Q3 - Results - Earnings Call Presentation

November 1, 2023 | finance.yahoo.com

Clover Health Promotes Karen Soares to General Counsel

October 17, 2023 | finance.yahoo.com

Clover Health to Report Third Quarter 2023 Financial Results on November 6, 2023

October 12, 2023 | finance.yahoo.com

Clinician Use of Clover Assistant is Associated with Earlier Identification and Management of Diabetes

September 22, 2023 | finance.yahoo.com

Clover Health to Present at Maxim Group Emerging Growth in A.I. Virtual Conference on September 26, 2023

September 20, 2023 | finance.yahoo.com

Clover Health to Host Virtual Clover Assistant Showcase on October 12, 2023

September 14, 2023 | msn.com

Walgreens unveils new healthcare strategy for long-term growth

August 29, 2023 | markets.businessinsider.com

What's Going On With Clover Health Investments Stock?

See More Headlines

Receive CLOV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Clover Health Investments and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 11/06/2023
Today: 12/09/2023
Fiscal Year End: 12/31/2023
Next Earnings (Estimated): 2/27/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Hospital & medical service plans
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:CLOV
CUSIP: N/A
CIK: 1801170
Web: www.cloverhealth.com
Phone: 201-432-2133
Fax: N/A
Employees: 656
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: $1.92
High Stock Price Target: $3.00
Low Stock Price Target: $1.25
Potential Upside/Downside: +101.7%
Consensus Rating: Hold
Rating Score (0-4): 2.00
Research Coverage: 3 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($0.48)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-338,840,000.00
Net Margins: -9.37%
Pretax Margin: -9.35%
Return on Equity: -75.65%
Return on Assets: -21.86%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 1.27
Quick Ratio: 1.27

Sales & Book Value

Annual Sales: $3.48 billion
Price / Sales: 0.13
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $0.73 per share
Price / Book: 1.30

Miscellaneous

Outstanding Shares: 487,640,000
Free Float: 381,240,000
Market Cap: $463.36 million
Optionable: Not Optionable
Beta: 1.91

Investing Strategies To Help Grow Your Retirement Income

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Key Executives

Mr. Vivek Garipalli (Age 44)
Co-Founder & Executive Chairman
Mr. Andrew Toy (Age 44)
Co-Founder, CEO & Director
Comp: $1.01M
Mr. Scott J. Leffler (Age 48)
Chief Financial Officer
Comp: $420.19k
Mr. Brady Priest J.D. (Age 46)
Chief Executive Officer of Home Care
Comp: $587.36k
Mr. Conrad Wai (Age 42)
Chief Technology Officer
Mr. Derrick L. Nueman
Head of Investor Relations & Corporate strategy
Ms. Wendy Richey
Chief Compliance Officer
Ms. Karen Soares
General Counsel, Senior VP & Corporate Secretary
Ms. Rachel Fish
Chief People Officer
Ms. Jamie L. Reynoso (Age 53)
Chief Executive Officer of Medicare Advantage
Comp: $461.74k

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

CLOV Stock Analysis - Frequently Asked Questions

Should I buy or sell Clover Health Investments stock right now?: 3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Clover Health Investments in the last year. There are currently 1 sell rating, 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" CLOV shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CLOV, but not buy additional shares or sell existing shares.
View CLOV analyst ratings or view top-rated stocks.
What is Clover Health Investments' stock price target for 2024?: 3 brokers have issued 12-month target prices for Clover Health Investments' stock. Their CLOV share price targets range from $1.25 to $3.00. On average, they predict the company's stock price to reach $1.92 in the next twelve months. This suggests a possible upside of 101.7% from the stock's current price.
View analysts price targets for CLOV or view top-rated stocks among Wall Street analysts.
How have CLOV shares performed in 2023?: Clover Health Investments' stock was trading at $0.9295 at the beginning of the year. Since then, CLOV shares have increased by 2.2% and is now trading at $0.9502.
View the best growth stocks for 2023 here.
Are investors shorting Clover Health Investments?: Clover Health Investments saw a increase in short interest in November. As of November 15th, there was short interest totaling 25,430,000 shares, an increase of 5.3% from the October 31st total of 24,150,000 shares. Based on an average daily volume of 4,110,000 shares, the short-interest ratio is currently 6.2 days.
View Clover Health Investments' Short Interest.

When is Clover Health Investments' next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 27th 2024.
View our CLOV earnings forecast.
How were Clover Health Investments' earnings last quarter?: Clover Health Investments, Corp. (NASDAQ:CLOV) issued its earnings results on Monday, November, 6th. The company reported ($0.09) earnings per share for the quarter, beating analysts' consensus estimates of ($0.10) by $0.01. The company earned $482.07 million during the quarter, compared to analysts' expectations of $491.30 million. Clover Health Investments had a negative trailing twelve-month return on equity of 75.65% and a negative net margin of 9.37%.
Who are Clover Health Investments' major shareholders?: Clover Health Investments' stock is owned by many different institutional and retail investors. Top institutional investors include PNC Financial Services Group Inc. (1.05%), Charles Schwab Investment Management Inc. (0.38%), Qube Research & Technologies Ltd (0.28%), Connor Clark & Lunn Investment Management Ltd. (0.17%), Northern Trust Corp (0.16%) and AQR Capital Management LLC (0.16%). Insiders that own company stock include Anna U Loengard, Chamath Palihapitiya, Chelsea Clinton and Lee Shapiro.
View institutional ownership trends.
How do I buy shares of Clover Health Investments?: Shares of CLOV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NASDAQ:CLOV) was last updated on 12/9/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial